ESR1 and cancer: However, the growing availability of technologies that permit spatial resolution and localize gene expression, and increasing incorporation of single cell sequencing analyses, will build our understanding of the major axes which fuel immunosuppression in ER+ cancers, and illuminate the contributions of estrogen activity and impact of therapeutic interventions.